286 related articles for article (PubMed ID: 25175359)
21. Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.
Minasi S; Baldi C; Pietsch T; Donofrio V; Pollo B; Antonelli M; Massimino M; Giangaspero F; Buttarelli FR
J Neurooncol; 2019 May; 142(3):435-444. PubMed ID: 30830680
[TBL] [Abstract][Full Text] [Related]
22. Inter-telomeric recombination is present in telomerase-positive human cells.
Dlaska M; Schöffski P; Bechter OE
Cell Cycle; 2013 Jul; 12(13):2084-99. PubMed ID: 23759591
[TBL] [Abstract][Full Text] [Related]
23. Alternative lengthening of telomeres can be maintained by preferential elongation of lagging strands.
Min J; Wright WE; Shay JW
Nucleic Acids Res; 2017 Mar; 45(5):2615-2628. PubMed ID: 28082393
[TBL] [Abstract][Full Text] [Related]
24. Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition.
Bechter OE; Zou Y; Walker W; Wright WE; Shay JW
Cancer Res; 2004 May; 64(10):3444-51. PubMed ID: 15150096
[TBL] [Abstract][Full Text] [Related]
25. Telomerase suppresses formation of ALT-associated single-stranded telomeric C-circles.
Plantinga MJ; Pascarelli KM; Merkel AS; Lazar AJ; von Mehren M; Lev D; Broccoli D
Mol Cancer Res; 2013 Jun; 11(6):557-67. PubMed ID: 23505069
[TBL] [Abstract][Full Text] [Related]
26. Alternative Lengthening of Telomeres (ALT) and Telomerase Reverse Transcriptase Promoter Methylation in Recurrent Adult and Primary Pediatric Pituitary Neuroendocrine Tumors.
Alzoubi H; Minasi S; Gianno F; Antonelli M; Belardinilli F; Giangaspero F; Jaffrain-Rea ML; Buttarelli FR
Endocr Pathol; 2022 Dec; 33(4):494-505. PubMed ID: 34993885
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis related to telomere instability and cell cycle alterations in human glioma cells treated by new highly selective G-quadruplex ligands.
Pennarun G; Granotier C; Gauthier LR; Gomez D; Hoffschir F; Mandine E; Riou JF; Mergny JL; Mailliet P; Boussin FD
Oncogene; 2005 Apr; 24(18):2917-28. PubMed ID: 15735722
[TBL] [Abstract][Full Text] [Related]
28. Telomere G-Quadruplex as a Potential Target to Accelerate Telomere Shortening by Expanding the Incomplete End-Replication of Telomere DNA.
Tan Z; Tang J; Kan ZY; Hao YH
Curr Top Med Chem; 2015; 15(19):1940-6. PubMed ID: 25980416
[TBL] [Abstract][Full Text] [Related]
29. Long interspersed element-1 ribonucleoprotein particles protect telomeric ends in alternative lengthening of telomeres dependent cells.
Aschacher T; Wolf B; Aschacher O; Enzmann F; Laszlo V; Messner B; Türkcan A; Weis S; Spiegl-Kreinecker S; Holzmann K; Laufer G; Ehrlich M; Bergmann M
Neoplasia; 2020 Feb; 22(2):61-75. PubMed ID: 31846834
[TBL] [Abstract][Full Text] [Related]
30. Telomere maintenance by telomerase and by recombination can coexist in human cells.
Cerone MA; Londono-Vallejo JA; Bacchetti S
Hum Mol Genet; 2001 Sep; 10(18):1945-52. PubMed ID: 11555631
[TBL] [Abstract][Full Text] [Related]
31. Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers.
Henson JD; Reddel RR
FEBS Lett; 2010 Sep; 584(17):3800-11. PubMed ID: 20542034
[TBL] [Abstract][Full Text] [Related]
32. WRN loss induces switching of telomerase-independent mechanisms of telomere elongation.
Gocha AR; Acharya S; Groden J
PLoS One; 2014; 9(4):e93991. PubMed ID: 24709898
[TBL] [Abstract][Full Text] [Related]
33. Functional Loss of
Graham MK; Kim J; Da J; Brosnan-Cashman JA; Rizzo A; Baena Del Valle JA; Chia L; Rubenstein M; Davis C; Zheng Q; Cope L; Considine M; Haffner MC; De Marzo AM; Meeker AK; Heaphy CM
Mol Cancer Res; 2019 Dec; 17(12):2480-2491. PubMed ID: 31611308
[TBL] [Abstract][Full Text] [Related]
34. Increased alternative lengthening of telomere phenotypes of telomerase-negative immortal cells upon trichostatin--a treatment.
Jung AR; Yoo JE; Shim YH; Choi YN; Jeung HC; Chung HC; Rha SY; Oh BK
Anticancer Res; 2013 Mar; 33(3):821-9. PubMed ID: 23482750
[TBL] [Abstract][Full Text] [Related]
35. G-quadruplex stabilizer Tetra-Pt(bpy) disrupts telomere maintenance and impairs FAK-mediated migration of telomerase-positive cells.
Shen Z; Zheng R; Yang H; Xing S; Jin X; Yan H; Zhu J; Mei Y; Lin F; Zheng X
Int J Biol Macromol; 2022 Jul; 213():858-870. PubMed ID: 35697164
[TBL] [Abstract][Full Text] [Related]
36. Life and cancer without telomerase: ALT and other strategies for making sure ends (don't) meet.
Apte MS; Cooper JP
Crit Rev Biochem Mol Biol; 2017 Feb; 52(1):57-73. PubMed ID: 27892716
[TBL] [Abstract][Full Text] [Related]
37. Alternative lengthening of telomeres (ALT) cells viability is dependent on C-rich telomeric RNAs.
Rosso I; Jones-Weinert C; Rossiello F; Cabrini M; Brambillasca S; Munoz-Sagredo L; Lavagnino Z; Martini E; Tedone E; Garre' M; Aguado J; Parazzoli D; Mione M; Shay JW; Mercurio C; d'Adda di Fagagna F
Nat Commun; 2023 Nov; 14(1):7086. PubMed ID: 37925537
[TBL] [Abstract][Full Text] [Related]
38. Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?
Nittis T; Guittat L; Stewart SA
Biochimie; 2008 Jan; 90(1):5-12. PubMed ID: 17935854
[TBL] [Abstract][Full Text] [Related]
39. Naphthalene diimide-derivatives G-quadruplex ligands induce cell proliferation inhibition, mild telomeric dysfunction and cell cycle perturbation in U251MG glioma cells.
Muoio D; Berardinelli F; Leone S; Coluzzi E; di Masi A; Doria F; Freccero M; Sgura A; Folini M; Antoccia A
FEBS J; 2018 Oct; 285(20):3769-3785. PubMed ID: 30095224
[TBL] [Abstract][Full Text] [Related]
40. Telomere recombination requires the MUS81 endonuclease.
Zeng S; Xiang T; Pandita TK; Gonzalez-Suarez I; Gonzalo S; Harris CC; Yang Q
Nat Cell Biol; 2009 May; 11(5):616-23. PubMed ID: 19363487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
